Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

JM Llovet, T De Baere, L Kulik, PK Haber… - Nature reviews …, 2021 - nature.com
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality and
has an increasing incidence worldwide. Locoregional therapies, defined as imaging-guided …
被引用次数：547 相关文章

Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

JM Llovet, T De Baere, L Kulik… - Nature Reviews …, 2021 - scholars.northwestern.edu
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality and
has an increasing incidence worldwide. Locoregional therapies, defined as imaging-guided …

Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

JM Llovet, PK Haber, T De Baere, L Kulik… - Nature Reviews …, 2021 - elibrary.ru
Locoregional therapies in the era of molecular and immune treatments for hepatocellular
carcinoma КОРЗИНА ПОИСК НАВИГАТОР ЖУРНАЛЫ КНИГИ ПАТЕНТЫ ПОИСК АВТОРЫ …

Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

JM Llovet, L Kulik, PK Haber, T Meyer… - Nature Reviews …, 2021 - search.proquest.com
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality and
has an increasing incidence worldwide. Locoregional therapies, defined as imaging-guided …

Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

JM Llovet, T De Baere, L Kulik… - Nature reviews …, 2021 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality and
has an increasing incidence worldwide. Locoregional therapies, defined as imaging-guided …

Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma.

JM Llovet, T De Baere, L Kulik, PK Haber… - Nature reviews …, 2021 - europepmc.org
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality and
has an increasing incidence worldwide. Locoregional therapies, defined as imaging-guided …

Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

JM Llovet, T De Baere, L Kulik, PK Haber… - NATURE REVIEWS …, 2021 - arpi.unipi.it
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality and
has an increasing incidence worldwide. Locoregional therapies, defined as imaging-guided …

[引用][C] Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

JM Llovet, T De Baere, L Kulik, PK Haber… - Nature Reviews …, 2021 - cir.nii.ac.jp
Locoregional therapies in the era of molecular and immune treatments for hepatocellular
carcinoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …